Israel’s RevitalVision (see here previously) has been very successful in improving the condition of the visually impaired. On average, the structured on-line brain exercises achieve a measurable improvement of 20 – 25%, equivalent to an extra two lines on a … Continue reading →

The nano-platform technology of Israel’s NanoCarry traverses the Blood Brain Barrier (BBB) to deliver potentially life-saving therapies to the brain.  Its initial target is HER2 breast cancer brain metastases for which there is no treatment, even though the original cancer … Continue reading →

Doctors saved an Israeli woman in her 50s after she was bitten by a snake in southern Israel. She was brought to Ashdod hospital by family members who also brought the snake.  Doctors were able to identify the snake and … Continue reading →

The US FDA has extended its approval of the Deep Transcranial Magnetic Stimulation system from Israel’s BrainsWay (see here previously). It can now be used to treat depression up to the patient’s 86th birthday. The previous maximum age limit was … Continue reading →

Israel’s Biolojic Design (see here previously) is partnering Merck, to develop molecules that could be the basis for therapies to treat cancer and other immunological disorders. The venture is potentially worth up to 350 million euros to the Israeli company. … Continue reading →

Ben-Gurion University has received a $1.3 million grant from the Gates Foundation to develop and validate a novel and safe approach for measuring immune responses to polioviruses. https://provaeducation.com/news/ben-gurion-university-scientist-to-contribute-to-the-eradication-of-polio/2466922/ https://www.bgu.ac.il/en/news-and-articles/hertz-gates-foundation-grant/

Israel’s United Hatzalah is appealing for funds to purchase a rapid response vehicle – known as a minilance (mini ambulance) ATV (all-terrain vehicle). It can bring a team of up to five UH volunteers and veteran lifesaving medics to the … Continue reading →

Scientists at Israel’s Technion Institute have developed optical sensor technology that can identify the correct antibiotic for urinary tract and other infections in just 90 minutes. They worked with Technion alumni in a Maryland USA company and at John Hopkins … Continue reading →

Back in 2015 (see here previously) Israel’s Ben Gurion University researchers discovered the link between protein macrophage migration inhibitory factor (MIF) and Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. Now they are leading an international team to … Continue reading →

Israel’s BiolineRX is to conduct Phase 1 clinical trials on sickle cell disease (SCD) patients at multiple locations in the US.  It will use its motixafortide stem cell therapy (see here previously), currently used to treat multiple myeloma. SCD is … Continue reading →